membran
protein
one
major
structur
protein
coronaviru
particl
studi
protein
transmiss
gastroenter
viru
tgev
use
biopan
phage
display
random
peptid
librari
three
phage
express
tgevmbind
peptid
identifi
character
depth
phagebas
immunosorb
assay
phageelisa
capabl
differenti
tgev
coronavirus
develop
use
one
phage
antigen
phageelisa
compar
convent
antibodybas
elisa
detect
infect
phageelisa
exhibit
greater
sensit
chemic
synthes
peptid
haltpikyippg
evalu
antivir
activ
plaquereduct
assay
reveal
abl
prevent
tgev
infect
vitro
p
follow
pretreat
viru
peptid
indirect
immunofluoresc
realtim
rtpcr
confirm
inhibitori
effect
peptid
result
indic
might
util
virusspecif
diagnost
treatment
transmiss
gastroenter
tge
highli
contagi
diseas
swine
character
mortal
suckl
piglet
laud
et
al
clinic
symptom
includ
acut
diarrhea
vomit
dehydr
pig
age
categori
suscept
seroneg
herd
tge
caus
devast
econom
loss
saif
wesley
yin
et
al
viru
respons
tge
tgev
glycoprotein
surfac
envelop
positivesens
rna
genom
approxim
kb
ortego
et
al
viru
consist
four
structur
protein
spike
small
membran
sm
e
membran
nucleocapsid
n
protein
spaan
et
al
saif
wesley
penz
et
al
protein
larg
transmembran
surfac
glycoprotein
induc
virusneutr
vn
antibodi
et
al
laud
et
al
et
al
n
protein
togeth
genom
rna
form
viral
nucleocapsid
cavanagh
sm
protein
regul
virion
assembl
releas
laud
et
al
protein
abund
compon
coronaviru
particl
rottier
roughli
onethird
protein
assum
topolog
part
endo
domain
constitut
fourth
transmembran
segment
therebi
posit
carboxi
terminu
exterior
portion
virion
risco
et
al
master
suggest
protein
induc
innat
immun
includ
interferon
product
charley
laud
laud
et
al
phage
display
power
technolog
appli
antibodi
engin
hayden
et
al
cyrankaczaja
otlewski
drug
discoveri
manufactur
kay
et
al
harper
et
al
ligand
identif
ehrlich
bailon
ladner
ley
yi
et
al
beer
liu
develop
new
diagnost
gazarian
et
al
vaccin
lesinski
westerink
samoylova
et
al
phage
display
yield
billion
heterolog
fusion
peptid
express
surfac
filament
bacteriophag
scott
smith
inasmuch
phage
express
one
fusion
peptid
technolog
permit
high
throughput
pan
phage
librari
intent
identifi
singl
phage
particl
capac
bind
target
protein
permit
epitop
map
easi
purif
margin
cost
current
studi
three
tgev
mbind
phage
concomit
peptid
identifi
phage
display
librari
result
indic
abil
peptid
function
tgevspecif
diagnost
reagent
one
peptid
studi
potenti
inhibitor
tgev
infect
swine
testi
st
cell
grown
dulbecco
mem
fetal
bovin
serum
co
tgev
strain
et
al
propag
st
cell
absenc
serum
follow
gradient
ultracentrifug
purif
krempl
herrler
cytopath
effect
cpe
assay
perform
describ
ren
et
al
briefli
st
cell
seed
onto
tissu
cultur
plate
costar
usa
inocul
seriallydilut
tgev
incub
h
cpe
record
magnif
use
microscop
optec
china
total
rna
isol
tgevinfect
st
cell
use
commerci
protocol
fastgen
china
sens
ggggggatccatgcgctattgtgctatg
antisens
ccccgaattcttataccatatgtaataa
primer
use
rtpcr
amplifi
gene
insert
bamhiecori
site
prokaryot
express
vector
pgex
novagen
germani
result
recombin
plasmid
pgextgevm
pgextgevm
transform
rosett
escherichia
coli
bacteria
heat
shock
bowyer
express
glutathion
stransferas
gst
taggedtgevm
fusion
protein
induc
isopropylbdthiogalactosid
iptg
visual
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
recombin
protein
interest
rtgevm
gel
purifi
ren
et
al
parallel
rgst
pgex
express
purifi
well
concentr
rtgevm
measur
spectrophotometr
use
nanodrop
spectrophotomet
accord
manufactur
instruct
biopan
phage
perform
use
phage
display
peptid
librari
kit
accord
manufactur
instruct
new
england
biolab
usa
minor
modif
ren
et
al
first
round
bind
phage
librari
rtgevm
lgwell
rtgevm
use
second
round
rtgevm
replac
rgst
neg
control
remov
nonspecif
bind
gst
round
perform
similar
condit
except
gradual
decreas
concentr
rtgevm
lgwell
increas
concentr
tween
increas
stringenc
bind
phage
remain
last
round
biopan
titer
select
phage
amplif
studi
phage
interact
posit
rtgevm
identifi
indirect
elisa
plate
jet
bio
china
coat
either
rtgevm
nahco
ph
purifi
tgev
dmem
lgwell
plate
block
bsa
tb
buffer
mm
trishcl
ph
mm
nacl
h
wash
tbstween
select
phage
deriv
last
round
biopan
ad
separ
well
concentr
plaqu
form
unit
pfu
ml
nahco
ph
incub
h
remain
step
perform
describ
ren
et
al
plate
read
od
biotek
usa
elisa
reader
viru
detect
use
elisa
ten
tgevposit
phage
clone
amplifi
use
e
coli
express
system
dna
interest
extract
purifi
qiagen
germani
pcr
amplifi
sequenc
corrobor
presenc
tgevm
sequenc
deduc
amino
acid
sequenc
determin
wu
et
al
phage
elisa
antibodyelisa
compar
abil
detect
presenc
viru
describ
wu
et
al
phageelisa
tgev
seriallydilut
dmem
coat
onto
elisa
plate
overnight
either
specif
phage
clone
nonspecif
phage
complex
neg
control
phage
display
librari
dilut
pb
ad
well
next
well
incub
commerciallyavail
rabbit
antibodi
pb
follow
horseradish
peroxidaseconjug
goat
antirabbit
antibodi
garp
pb
antibodymedi
elisa
rabbit
immun
mg
rtgevm
freund
complet
adjuv
follow
three
addit
immun
week
interv
amount
antigen
freund
incomplet
adjuv
anim
bled
day
final
boost
tgev
coat
onto
elisa
plate
ad
rabbit
antitgevm
follow
garp
secondari
antibodi
experi
concentr
tgev
determin
experiment
elisa
valu
could
measur
od
phage
p
od
neg
control
n
consid
posit
specif
tgevreact
phage
tgev
infect
evalu
phageelisa
panel
select
virus
prepar
laboratori
consist
tgev
ren
et
al
porcin
epidem
diarrhea
viru
pedv
strain
hljbi
porcin
reproduct
respiratori
syndrom
viru
prrsv
strain
gao
et
al
porcin
rotaviru
prv
ren
et
al
porcin
pseudorabi
viru
prv
strain
kaplan
sui
et
al
porcin
parvoviru
ppv
isol
porcin
circoviru
type
ii
strain
zhu
ren
assembl
compar
studi
virus
dilut
dmem
final
concentr
lgwell
coat
onto
elisa
plate
h
elisa
perform
accord
standard
protocol
wu
et
al
unpan
phage
display
peptid
librari
phage
l
use
neg
control
statist
signific
od
valu
among
viral
antigen
evalu
od
viru
od
phage
l
judg
posit
subsequ
analyz
use
ttest
amino
acid
sequenc
correspond
phage
highest
bind
activ
tgev
commerci
synthes
boshi
china
peptid
dilut
steril
water
final
concentr
mgml
purifi
rtgevm
control
protein
rtgev
sad
meng
et
al
coat
onto
elisa
plate
lgwell
seriallydilut
lgml
mix
phtgevsad
pfuml
incub
h
wash
well
incub
rabbit
antibodi
dilut
abcam
china
h
follow
dilut
garp
min
od
valu
record
three
experiment
approach
use
evalu
antivir
activ
miyazaki
et
al
ren
et
al
first
assess
abil
peptid
bind
tgev
vitro
tgev
preincub
lgml
infect
st
cell
second
determin
impact
st
cell
cell
treat
seriallydilut
peptid
h
prior
tgev
infect
final
determin
effect
st
cell
tgev
infect
cell
first
infect
tgev
h
wash
incub
seriallydilut
h
cell
grown
confluenc
plate
overlaid
methylcellulos
cultur
h
maxim
plaqu
develop
evalu
effect
tgev
replic
vitro
indirect
immunofluoresc
assay
ifa
perform
briefli
confluent
st
cell
incub
peptidetr
tgev
serial
dilut
peptid
incub
tgev
h
process
ifa
previous
describ
meng
et
al
unrel
peptid
bind
protein
dilut
use
neg
control
impact
viru
replic
evalu
real
time
rtpcr
target
portion
tgev
gene
tgev
treat
seriallydilut
peptid
rang
lgml
h
lgml
use
neg
control
wash
st
cell
pb
confluent
monolay
infect
peptid
treat
tgev
h
viruscontain
cultur
frozen
thaw
three
time
follow
addit
equal
volum
room
temperatur
min
sampl
centrifug
rpm
min
pellet
suspend
rnasefre
water
total
rna
extract
accord
manufactur
instruct
fastgen
china
realtim
rtpcr
perform
cdna
describ
ren
et
al
anticip
detriment
effect
viral
infect
would
reflect
significantli
reduc
number
tgev
gene
copi
use
previous
describ
techniqu
ren
et
al
rtgevm
protein
express
e
coli
fig
use
biopan
phage
display
librari
identifi
peptid
bind
protein
tgev
isol
process
determin
rtgevm
present
within
inclus
bodi
peak
express
observ
h
postiptg
induct
mass
rtgevm
kda
fig
five
round
biopan
perform
use
rtgevm
target
one
addit
round
gst
target
amount
elut
phage
increas
round
respect
ten
differ
tgevm
proteinreact
phage
identifi
elisa
rtgevm
use
coat
antigen
fig
ten
phage
exhibit
better
bind
rtgevm
phageexpress
protein
control
p
fig
phage
higher
bind
affin
p
tgev
phage
fig
among
ten
reactiv
phage
bound
rtgevm
high
affin
exhibit
highest
bind
tgev
p
fig
follow
rna
sampl
isol
tgevmreact
control
phage
amplifi
rtpcr
sampl
yield
product
approxim
bp
length
data
shown
deduc
peptid
aa
length
uniqu
tabl
phage
bear
peptid
ltfpvtttppav
mthnmhgpnsep
haltpikyippg
select
highaffin
bind
rtgevm
fig
tgev
fig
three
peptid
name
respect
bind
effici
select
tgevmreact
phage
examin
phageelisa
viru
concentr
lgwell
exceed
signal
limit
assay
illustr
fig
titrat
viru
concentr
fell
rang
ugwel
lowest
concentr
viru
detect
pn
p
lgwell
respect
antibodybas
elisa
rabbit
antibodi
titer
rtgevm
pn
p
determin
assay
antibodi
bind
tgev
viru
concentr
seriallydilut
tgev
dmem
coat
elisa
plate
follow
incub
seriallydilut
rabbit
tgev
serum
antibodi
bind
use
garp
normal
rabbit
serum
use
neg
control
od
ratio
pn
consid
posit
experi
determin
od
valu
deriv
three
independ
assay
concentr
viru
indic
x
axi
antibodi
viru
dilut
indic
lgml
pn
valu
began
exceed
limit
detect
viru
lgwell
reproduc
detect
pn
p
antibodi
dilut
less
fig
bind
specif
nontg
virus
examin
fig
case
p
n
tgev
demonstr
bind
observ
virus
test
result
show
bound
rtgevm
bind
protein
fig
increas
concentr
effect
compet
bind
rtgevm
evidenc
decreas
od
valu
howev
compet
phage
bind
nonspecif
protein
rtgevsad
use
coat
antigen
fig
determin
impact
tgev
infect
three
separ
approach
use
tgev
treat
peptid
inocul
st
cell
st
cell
treat
peptid
prior
tgev
inocul
st
cell
infect
tgev
treat
peptid
expect
result
show
impact
st
cell
alreadi
infect
tgev
st
cell
pretreat
prior
incub
viru
data
shown
howev
tgev
preincub
infect
decreas
dosedepend
manner
lgml
drop
infect
nearli
wherea
lgml
drop
viru
infect
observ
tabl
suggest
peak
inhibit
reach
data
indic
abl
interfer
abil
viru
infect
st
cell
antivir
effect
viru
investig
ifa
result
demonstr
dosedepend
reduct
infect
st
cell
presenc
wherea
unrel
peptid
effect
viru
uptak
fig
realtim
rtpcr
use
confirm
quantifi
tgev
inhibitori
effect
fig
result
show
amount
viral
rna
lower
p
tgev
pretreat
peptideuntr
control
highest
concentr
lgml
viru
rna
level
drop
howev
signific
p
reproduc
reduct
observ
ugml
use
data
corrobor
ifa
studi
despit
avail
commerci
vaccin
tge
still
pose
region
threat
swine
industri
due
high
morbid
mortal
tgev
caus
suckl
piglet
week
age
miyazaki
et
al
although
passiv
lactogen
immun
induc
virul
attenu
tgev
vaccin
provid
effect
protect
suffici
risk
remain
albeit
safer
inactiv
rtgev
protein
monitor
use
antibodi
garp
secondari
antibodi
target
parallel
rtgev
sad
screen
neg
control
concentr
shown
axi
statist
signific
indic
p
p
rel
control
experi
perform
triplic
vaccin
provid
less
protect
accur
diagnost
test
need
better
effect
tge
prevent
therapi
phage
display
biopan
power
method
identifi
key
ligand
within
larg
target
antigen
may
involv
protect
andor
diagnosi
wu
et
al
technolog
use
identifi
receptor
bind
domain
rbd
tgev
may
interact
papn
cellular
receptor
ren
et
al
also
use
identifi
immunogen
protein
pig
sera
convalesc
anim
histori
salmonella
typhimurium
infect
meyer
et
al
target
tissu
like
bonemarrow
dendrit
cell
kidney
liver
lung
spleen
viscer
adipos
tissu
jung
et
al
sinc
protein
one
three
major
tgev
structur
protein
use
target
biopan
phage
display
peptid
librari
identifi
peptid
ultim
inhibit
viru
bind
end
tgevm
protein
first
express
e
coli
gst
fusion
protein
given
possibl
identifi
gstbind
phage
includ
addit
pan
step
use
purifi
recombin
gst
target
remov
phage
specif
target
rtgevm
protein
also
stringenc
systemat
increas
pan
decreas
concentr
rtgevm
increas
concentr
three
tgevm
phage
identifi
studi
evalu
elisa
detect
tgev
infect
result
show
wide
use
tgevm
antibodyelisa
phageelisa
could
detect
viru
success
howev
phageelsia
costeffect
involv
anim
phage
unlimit
suppli
even
use
serum
anim
boost
peptid
concentr
ugml
rel
amplic
fig
inhibit
viru
infect
monitor
rtpcr
real
time
rtpcr
use
quantifi
tgev
rna
st
cell
therefor
viru
infect
pcr
perform
tgev
sad
gene
tgev
viru
preincub
seriallydilut
lgml
peptid
ad
st
cell
h
unrel
peptid
maxim
concentr
use
control
virusderiv
cdna
amplifi
dct
valu
measur
triplic
rel
amplif
tgev
sad
tgevinfect
cell
normal
betaactin
calcul
use
method
statist
signific
indic
p
rel
lgml
peptid
rtgevm
phageelisa
appear
sensit
clearli
target
protein
rather
whole
viru
could
sacrific
sensit
although
demonstr
specif
phage
peptid
bind
rtgevm
determin
wellexpos
bind
region
surfac
viru
use
protein
biopan
agent
probabl
effect
use
whole
viru
also
may
contribut
lower
expect
signal
strength
polyclon
abelisa
especi
ab
titer
use
rtgevm
protein
antigen
high
use
antivir
repres
one
approach
treat
coronaviru
infect
ren
et
al
studi
peptid
encod
interact
rtgevm
protein
synthes
interact
deem
specif
titrat
similar
result
observ
interact
anoth
tgev
structur
protein
rtgev
sad
meng
et
al
plaquereduct
assay
show
tgev
infect
decreas
viru
pretreat
peptid
contrast
incub
st
cell
alon
tgevinfect
st
cell
inhibitori
effect
observ
expect
outcom
given
rtgevm
use
pan
bioreact
phage
protein
present
surfac
within
st
cell
collect
data
present
consist
bind
surfac
viru
either
interf
abil
viru
invad
cell
gener
progeni
viru
neither
incub
peptid
st
cell
prior
ad
viru
demonstr
effect
replic
virusspecif
effect
confirm
ifa
rtpcr
summari
peptid
sequenc
recogn
tgevm
protein
identifi
studi
use
phage
display
technolog
phage
bear
peptid
may
util
serologybas
diagnosi
tge
direct
inhibitori
effect
tgev
infect
vitro
futur
research
peptid
identifi
studi
may
subject
antivir
test
